February 6, 2012
Last month, the New York Academy of Sciences (NYAS) held an event, Biomarkers and Brain Imaging of Presymptomatic Alzheimer's Disease: Exploring the Silent Years, organized in part by Covance Biomarker Center of Excellence Neuroscience Expert Robert Martone.
It was an interesting symposium, featuring talks from five different investigators studying very early, presymptomatic Alzheimer's Disease. Each of the five 40 minute presentations covered something different: defining cohorts for secondary prevention trials; markers of preclinical and clinical AD; multimodal imaging to identify microstructural alterations in brain white matter; event-related potentials (ERPs) and functional MRI (fMRI) to evaluate memory function; and plasma and CSF-based biomarkers for mild cognitive impairment (MCI) and AD.
If you're interested in learning more, a review of the event including several speaker comments is posted at Biomarker Commons: NYAS Symposium Review, Biomarkers and Brain Imaging of Presymptomatic Alzheimer's Disease.